Would it not make sense to focus on the US market first like most other US drug companies. This is solid proof that this is all smoke and mirrors. Less of a trail for this sham.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.